Atogepant — Active Pharmaceutical Ingredient

Atogepant is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: TABLET. Routes: ORAL.

Drug Ingredients A–Z 1 min read
This content is for informational purposes only. Always consult a healthcare professional.

Atogepant (1 brand name, 1 dosage form, 1 route)

Available dosage forms: TABLET.

Routes of administration: ORAL.

Brand Names

  • QULIPTA

Indications and Usage

QULIPTA is indicated for the preventive treatment of migraine in adults.

Contraindications

QULIPTA is contraindicated in patients with a history of hypersensitivity to atogepant or any of the components of QULIPTA. Reactions have included anaphylaxis and dyspnea [see Warnings and Precautions ( 5.1 )].

Adverse Reactions

The following clinically significant adverse reactions are described elsewhere in the labeling: Hypersensitivity Reactions [see Warnings and Precautions ( 5.1 )] Hypertension [see Warnings and Precautions ( 5.2 )] Raynaud’s Phenomenon [see Warnings and Precautions ( 5.3 )]

Mechanism of Action

Atogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.